Advertisement
ARES vs BN
Which Stock Would AI Choose? Ares Management Corporation (ARES) vs. Brookfield Corporation (BN) Stock Comparison
1) Key Takeaways
- Ares Management Corporation (ARES) is a pure-play alternative asset manager with a dominant private credit franchise, while Brookfield Corporation (BN) blends asset management with insurance and directly owned operating businesses.
- ARES posted record fundraising despite a sector-wide pullback in private credit sentiment; BN delivered steadier distributable earnings growth and aggressively repurchased its own discounted shares.
- ARES carries a higher fee-driven, credit-sensitive profile; BN offers broader diversification across real assets, infrastructure, energy, and insurance.
- Both stocks have underperformed their management-implied valuations at points in recent quarters, drawing attention from value-oriented and income-focused investors.
2) Introduction
Investors comparing alternative asset managers often weigh a specialist against a diversified conglomerate, and that is precisely the contrast between ARES and BN. Ares Management Corporation has built its reputation on private credit and fee-related earnings, while Brookfield Corporation operates a broader ecosystem spanning asset management, wealth and insurance solutions, and hard-asset operating businesses. This stock comparison is relevant for traders and investors assessing relative performance, market positioning, and how each company navigates shifting credit and interest-rate conditions. Understanding their distinct business models helps clarify which profile might suit a given portfolio objective in the current market environment.
3) ARES Overview and Recent Performance
Ares Management Corporation is a leading global alternative investment manager best known for its credit platform, alongside private equity, real estate, and infrastructure strategies. Its business is heavily anchored in fee-related earnings, a measure of the stable management fees earned on assets under management (AUM). In recent quarters, ARES reported record fundraising — roughly $30 billion in the first quarter of 2026 — even as the broader private credit sector faced scrutiny and negative headlines around lending standards and retail-fund redemptions.
Despite strong underlying fundamentals, ARES shares declined sharply earlier in the year, reflecting investor anxiety about private credit exposure to areas such as software lending. AUM nevertheless grew approximately 18% year over year to around $644 billion, and fee-related earnings rose roughly 26%. Management pointed to record institutional demand and a robust investment pipeline, framing market dislocations as an opportunity. This combination of strong fundamentals and elevated sector-level sentiment risk has made ARES a focal point of recent market activity.
4) BN Overview and Recent Performance
Brookfield Corporation is a global investment firm whose earnings come from asset management, wealth solutions (including insurance and annuities), and directly owned operating businesses in real estate, infrastructure, energy, and private equity. In recent quarters, BN reported distributable earnings before realizations of about $1.4 billion, a year-over-year increase of roughly 7%, driven by an 11% rise in fee-related earnings and a 12% increase in fee-bearing capital.
BN has also been actively simplifying its corporate structure, completing its acquisition of Just Group to expand its insurance platform, and deploying capital into AI (artificial intelligence) infrastructure, including a strategic partnership with OpenAI. Management has repurchased over $1 billion of stock, citing a share price trading at a meaningful discount to its estimated intrinsic value. These moves reflect a steadier, more diversified earnings profile, though BN's complexity and lower dividend yield relative to some peers are considerations investors weigh in their analysis.
5) Trending AI Robots
For traders seeking a systematic edge, Tickeron's Trending AI Robots page curates a selection of AI trading bots from a library of hundreds available on the platform, each trading different tickers with distinct strategies, timeframes, and risk profiles. Because market conditions change constantly, only the bots best suited to the current environment earn a place in this curated section. These bots vary in trading style, performance statistics, and the sets of securities they monitor, allowing users to filter for approaches that match their own objectives. Exploring the Trending AI Robots page can help investors identify systematic tools aligned with prevailing market dynamics.
6) Head-to-Head Comparison
The core trade-off between these two stocks is specialization versus diversification. ARES generates a large share of its value from credit-related management fees, giving it high earnings visibility but concentrated exposure to private credit sentiment and default-cycle concerns. BN spreads risk across asset management, insurance, and hard-asset operating businesses, providing balance but a more complex corporate structure that can be harder to value.
In terms of recent momentum, ARES has shown greater volatility, with strong quarterly results offset by sector-level selling pressure. BN has exhibited more measured movement, supported by buybacks, structural simplification, and diversified cash flows. Growth drivers also differ: ARES leans on record fundraising and deployment into direct lending, while BN emphasizes AI infrastructure, insurance expansion, and asset monetizations. On risk factors, ARES is more exposed to credit spreads and redemption flows in non-traded funds, whereas BN faces execution risk tied to corporate restructuring and cross-border insurance integration.
7) Tickeron AI Verdict
Based on observable factors, Tickeron's AI would likely express a modest relative preference for BN in the current environment, though the distinction is narrow. BN's trend profile benefits from steadier distributable earnings growth, active share repurchases, and a diversified revenue base that is less concentrated in any single sentiment-driven segment. ARES, by contrast, presents stronger fee-based earnings momentum and record fundraising but also carries greater exposure to private credit headline risk, which has weighed on its relative performance in recent periods. A systematic model would therefore tend to favor BN's combination of stability, catalysts, and valuation support, while continuing to monitor ARES for a sentiment inflection. This assessment reflects probabilistic, data-driven positioning rather than a definitive forecast.
8) Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARES is a StrongBuy and BN is a StrongBuy.
Momentum Indicator for ARES turns positive, indicating new upward trend
ARES saw its Momentum Indicator move above the 0 level on October 21, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned positive. In 75 of the 98 cases, the stock moved higher in the following days. The odds of a move higher are at 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ARES's RSI Indicator exited the oversold zone, 15 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for ARES just turned positive on October 12, 2026. Looking at past instances where ARES's MACD turned positive, the stock continued to rise in 33 of 46 cases over the following month. The odds of a continued upward trend are 72%.
Following a +6.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARES advanced for three days, in 255 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
Bearish Trend Analysis
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for ARES crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARES declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
ARES broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ARES entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. ARES’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ARES's P/B Ratio (11.218) is slightly higher than the industry average of (2.404). P/E Ratio (56.743) is within average values for comparable stocks, (-3.413). Projected Growth (PEG Ratio) (0.879) is also within normal values, averaging (1.319). Dividend Yield (0.044) settles around the average of (0.272) among similar stocks. P/S Ratio (4.623) is also within normal values, averaging (15.798).
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
BN's RSI Indicator climbs out of oversold territory
The RSI Indicator for BN moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 20 of the 26 cases the stock moved higher. This puts the odds of a move higher at 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on BN as a result. In 59 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for BN just turned positive on September 29, 2026. Looking at past instances where BN's MACD turned positive, the stock continued to rise in 27 of 46 cases over the following month. The odds of a continued upward trend are 59%.
Following a +2.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where BN advanced for three days, in 225 of 340 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.
BN broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 56 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. BN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.011) is normal, around the industry mean (2.404). P/E Ratio (68.357) is within average values for comparable stocks, (-3.413). Projected Growth (PEG Ratio) (0.110) is also within normal values, averaging (1.319). Dividend Yield (0.007) settles around the average of (0.272) among similar stocks. P/S Ratio (1.135) is also within normal values, averaging (15.798).
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
ARES | BN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 37 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | 83 Overvalued | |
PROFIT vs RISK RATING 1..100 | 62 | 56 | |
SMR RATING 1..100 | 95 | 87 | |
PRICE GROWTH RATING 1..100 | 60 | 70 | |
P/E GROWTH RATING 1..100 | 82 | 92 | |
SEASONALITY SCORE 1..100 | 90 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BN's Valuation (83) in the Investment Managers industry is in the same range as ARES (91). This means that BN’s stock grew similarly to ARES’s over the last 12 months.
BN's Profit vs Risk Rating (56) in the Investment Managers industry is in the same range as ARES (62). This means that BN’s stock grew similarly to ARES’s over the last 12 months.
BN's SMR Rating (87) in the Investment Managers industry is in the same range as ARES (95). This means that BN’s stock grew similarly to ARES’s over the last 12 months.
ARES's Price Growth Rating (60) in the Investment Managers industry is in the same range as BN (70). This means that ARES’s stock grew similarly to BN’s over the last 12 months.
ARES's P/E Growth Rating (82) in the Investment Managers industry is in the same range as BN (92). This means that ARES’s stock grew similarly to BN’s over the last 12 months.
| ARES | BN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 77% |
| Stochastic ODDS (%) | 1 day ago 58% | 1 day ago 60% |
| Momentum ODDS (%) | 1 day ago 77% | 1 day ago 74% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 59% |
| TrendWeek ODDS (%) | 1 day ago 76% | 1 day ago 67% |
| TrendMonth ODDS (%) | 1 day ago 67% | 1 day ago 61% |
| Advances ODDS (%) | 1 day ago 76% | 1 day ago 66% |
| Declines ODDS (%) | 9 days ago 66% | 4 days ago 67% |
| BollingerBands ODDS (%) | 1 day ago 58% | 1 day ago 57% |
| Aroon ODDS (%) | 1 day ago 65% | 1 day ago 55% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARES’s FA Score shows that 0 FA rating(s) are green while BN’s FA Score has 0 green FA rating(s).
- ARES’s FA Score: 0 green, 5 red.
- BN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARES’s TA Score shows that 4 TA indicator(s) are bullish while BN’s TA Score has 4 bullish TA indicator(s).
- ARES’s TA Score: 4 bullish, 5 bearish.
- BN’s TA Score: 4 bullish, 4 bearish.
Price Growth
ARES (@Investment Managers) experienced а +8.48% price change this week, while BN (@Investment Managers) price change was +3.99% for the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was -1.39%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -0.93%.
Reported Earning Dates
ARES is expected to report earnings on Oct 29, 2026.
BN is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Investment Managers (-1.39% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
Advertisement
ARES and
Correlation & Price change
A.I.dvisor indicates that over the last year, ARES has been closely correlated with KKR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if ARES jumps, then KKR could also see price increases.
| Ticker / NAME | Correlation To ARES | 1D Price Change % | ||
|---|---|---|---|---|
| ARES | 100% | +5.72% | ||
| KKR - ARES | 83% Closely correlated | +3.58% | ||
| BX - ARES | 80% Closely correlated | +8.38% | ||
| TPG - ARES | 79% Closely correlated | +4.74% | ||
| OWL - ARES | 78% Closely correlated | +5.89% | ||
| APO - ARES | 77% Closely correlated | +2.81% | ||
More | ||||